

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mitochondrial translation (GO:0070129) | 4.08010031 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 3.95740876 |
| 3 | proteasome assembly (GO:0043248) | 3.95584329 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.92693178 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91822114 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 3.91822114 |
| 7 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.91183438 |
| 8 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.87356190 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.86154889 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.86129982 |
| 11 | central nervous system myelination (GO:0022010) | 3.81841263 |
| 12 | axon ensheathment in central nervous system (GO:0032291) | 3.81841263 |
| 13 | succinate metabolic process (GO:0006105) | 3.77836973 |
| 14 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.75115727 |
| 15 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.72692840 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.66796570 |
| 17 | fatty acid elongation (GO:0030497) | 3.66645647 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 3.63005384 |
| 19 | oxidative phosphorylation (GO:0006119) | 3.59243934 |
| 20 | actin-myosin filament sliding (GO:0033275) | 3.54197534 |
| 21 | muscle filament sliding (GO:0030049) | 3.54197534 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.53828434 |
| 23 | tryptophan catabolic process (GO:0006569) | 3.51642580 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 3.51642580 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 3.51642580 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.51084483 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 3.51084483 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 3.48224991 |
| 29 | regulation of cilium movement (GO:0003352) | 3.47575868 |
| 30 | maturation of 5.8S rRNA (GO:0000460) | 3.47407369 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.45914296 |
| 32 | nucleotide transmembrane transport (GO:1901679) | 3.37604784 |
| 33 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.35463698 |
| 34 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.33740682 |
| 35 | tryptophan metabolic process (GO:0006568) | 3.30526009 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 3.25434598 |
| 37 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24856888 |
| 38 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24856888 |
| 39 | protein neddylation (GO:0045116) | 3.23355038 |
| 40 | actin-mediated cell contraction (GO:0070252) | 3.18285558 |
| 41 | inner mitochondrial membrane organization (GO:0007007) | 3.17387464 |
| 42 | amine catabolic process (GO:0009310) | 3.16638295 |
| 43 | cellular biogenic amine catabolic process (GO:0042402) | 3.16638295 |
| 44 | opsonization (GO:0008228) | 3.14422385 |
| 45 | cullin deneddylation (GO:0010388) | 3.13535742 |
| 46 | respiratory electron transport chain (GO:0022904) | 3.12760377 |
| 47 | biotin metabolic process (GO:0006768) | 3.11003462 |
| 48 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.10608192 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.07903387 |
| 50 | regulation of coenzyme metabolic process (GO:0051196) | 3.07161003 |
| 51 | regulation of cofactor metabolic process (GO:0051193) | 3.07161003 |
| 52 | otic vesicle formation (GO:0030916) | 3.03807686 |
| 53 | electron transport chain (GO:0022900) | 3.03360022 |
| 54 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 3.02584411 |
| 55 | NAD biosynthetic process (GO:0009435) | 3.01339620 |
| 56 | valine metabolic process (GO:0006573) | 3.01021675 |
| 57 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.00049564 |
| 58 | organelle disassembly (GO:1903008) | 2.98544057 |
| 59 | GPI anchor biosynthetic process (GO:0006506) | 2.96437427 |
| 60 | regulation of sulfur metabolic process (GO:0042762) | 2.95405121 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 2.91833250 |
| 62 | ribonucleoprotein complex disassembly (GO:0032988) | 2.91420945 |
| 63 | GPI anchor metabolic process (GO:0006505) | 2.90717734 |
| 64 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.88789468 |
| 65 | bile acid biosynthetic process (GO:0006699) | 2.85799775 |
| 66 | uronic acid metabolic process (GO:0006063) | 2.85148265 |
| 67 | glucuronate metabolic process (GO:0019585) | 2.85148265 |
| 68 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.84565987 |
| 69 | short-chain fatty acid metabolic process (GO:0046459) | 2.84460663 |
| 70 | adenosine metabolic process (GO:0046085) | 2.84211979 |
| 71 | aldehyde catabolic process (GO:0046185) | 2.84079192 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 2.83309863 |
| 73 | anterograde synaptic vesicle transport (GO:0048490) | 2.81251212 |
| 74 | negative regulation of lipase activity (GO:0060192) | 2.80810198 |
| 75 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.80344784 |
| 76 | ketone body metabolic process (GO:1902224) | 2.79355253 |
| 77 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.79330387 |
| 78 | presynaptic membrane assembly (GO:0097105) | 2.78577180 |
| 79 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.77300384 |
| 80 | lipid particle organization (GO:0034389) | 2.76367117 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 2.76210526 |
| 82 | mannosylation (GO:0097502) | 2.75166009 |
| 83 | CENP-A containing nucleosome assembly (GO:0034080) | 2.73737740 |
| 84 | cellular glucuronidation (GO:0052695) | 2.73141497 |
| 85 | kynurenine metabolic process (GO:0070189) | 2.72763177 |
| 86 | glyoxylate metabolic process (GO:0046487) | 2.71339605 |
| 87 | indolalkylamine metabolic process (GO:0006586) | 2.70174583 |
| 88 | chromatin remodeling at centromere (GO:0031055) | 2.65291340 |
| 89 | carnitine metabolic process (GO:0009437) | 2.64700635 |
| 90 | limb bud formation (GO:0060174) | 2.64274740 |
| 91 | replication fork processing (GO:0031297) | 2.63432562 |
| 92 | pseudouridine synthesis (GO:0001522) | 2.62986613 |
| 93 | aromatic amino acid family metabolic process (GO:0009072) | 2.62939799 |
| 94 | protein deneddylation (GO:0000338) | 2.62015533 |
| 95 | respiratory chain complex IV assembly (GO:0008535) | 2.60949680 |
| 96 | polyol catabolic process (GO:0046174) | 2.60719596 |
| 97 | signal peptide processing (GO:0006465) | 2.60363308 |
| 98 | coenzyme catabolic process (GO:0009109) | 2.60024558 |
| 99 | xenobiotic catabolic process (GO:0042178) | 2.58572241 |
| 100 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.58063770 |
| 101 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.57992515 |
| 102 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.57992515 |
| 103 | NADH dehydrogenase complex assembly (GO:0010257) | 2.57992515 |
| 104 | ATP synthesis coupled proton transport (GO:0015986) | 2.57447170 |
| 105 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.57447170 |
| 106 | fatty acid transmembrane transport (GO:1902001) | 2.56950567 |
| 107 | phospholipid efflux (GO:0033700) | 2.56709503 |
| 108 | protein complex biogenesis (GO:0070271) | 2.56395277 |
| 109 | histone mRNA metabolic process (GO:0008334) | 2.54996601 |
| 110 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.53830679 |
| 111 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.53830679 |
| 112 | regulation of pigment cell differentiation (GO:0050932) | 2.53356371 |
| 113 | very long-chain fatty acid metabolic process (GO:0000038) | 2.52021857 |
| 114 | presynaptic membrane organization (GO:0097090) | 2.50102095 |
| 115 | intracellular protein transmembrane import (GO:0044743) | 2.49810523 |
| 116 | ubiquinone biosynthetic process (GO:0006744) | 2.49556811 |
| 117 | quinone biosynthetic process (GO:1901663) | 2.49556811 |
| 118 | C-terminal protein lipidation (GO:0006501) | 2.49384948 |
| 119 | polyol transport (GO:0015791) | 2.48888425 |
| 120 | tyrosine metabolic process (GO:0006570) | 2.47990997 |
| 121 | nucleoside diphosphate catabolic process (GO:0009134) | 2.47335863 |
| 122 | cellular respiration (GO:0045333) | 2.46588863 |
| 123 | sarcomere organization (GO:0045214) | 2.45897369 |
| 124 | response to nitrosative stress (GO:0051409) | 2.45571800 |
| 125 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.45469143 |
| 126 | regulation of activation of Janus kinase activity (GO:0010533) | 2.45297811 |
| 127 | cofactor catabolic process (GO:0051187) | 2.45239743 |
| 128 | positive regulation of developmental pigmentation (GO:0048087) | 2.45088707 |
| 129 | glycogen biosynthetic process (GO:0005978) | 2.44648219 |
| 130 | glucan biosynthetic process (GO:0009250) | 2.44648219 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 2.44310302 |
| 132 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.44080064 |
| 133 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.43486117 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.43486117 |
| 135 | recombinational repair (GO:0000725) | 2.43218803 |
| 136 | C-terminal protein amino acid modification (GO:0018410) | 2.43084731 |
| 137 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.43046314 |
| 138 | low-density lipoprotein particle remodeling (GO:0034374) | 2.42651663 |
| 139 | ubiquinone metabolic process (GO:0006743) | 2.41931488 |
| 140 | nucleotide transport (GO:0006862) | 2.40648191 |
| 141 | high-density lipoprotein particle remodeling (GO:0034375) | 2.39400810 |
| 142 | fatty acid beta-oxidation (GO:0006635) | 2.39260203 |
| 143 | lipid oxidation (GO:0034440) | 2.39244480 |
| 144 | fatty acid oxidation (GO:0019395) | 2.39166843 |
| 145 | fatty acid catabolic process (GO:0009062) | 2.39158393 |
| 146 | cytochrome complex assembly (GO:0017004) | 2.38042171 |
| 147 | bile acid metabolic process (GO:0008206) | 2.36942192 |
| 148 | regulation of fibrinolysis (GO:0051917) | 2.35535676 |
| 149 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.34481669 |
| 150 | regulation of sequestering of triglyceride (GO:0010889) | 2.33775519 |
| 151 | isoprenoid biosynthetic process (GO:0008299) | 2.31559834 |
| 152 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30108451 |
| 153 | monocarboxylic acid catabolic process (GO:0072329) | 2.29169085 |
| 154 | cholesterol efflux (GO:0033344) | 2.27289114 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.27104958 |
| 156 | polyketide metabolic process (GO:0030638) | 2.27104958 |
| 157 | doxorubicin metabolic process (GO:0044598) | 2.27104958 |
| 158 | cholesterol biosynthetic process (GO:0006695) | 2.26954838 |
| 159 | positive regulation of action potential (GO:0045760) | 2.26331420 |
| 160 | branched-chain amino acid metabolic process (GO:0009081) | 2.25510810 |
| 161 | eye photoreceptor cell differentiation (GO:0001754) | 2.23696268 |
| 162 | photoreceptor cell differentiation (GO:0046530) | 2.23696268 |
| 163 | amino-acid betaine metabolic process (GO:0006577) | 2.23422772 |
| 164 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.23120251 |
| 165 | omega-hydroxylase P450 pathway (GO:0097267) | 2.22743886 |
| 166 | quinone metabolic process (GO:1901661) | 2.22184335 |
| 167 | positive regulation of protein homodimerization activity (GO:0090073) | 2.22142623 |
| 168 | plasma lipoprotein particle remodeling (GO:0034369) | 2.21886825 |
| 169 | protein-lipid complex remodeling (GO:0034368) | 2.21886825 |
| 170 | macromolecular complex remodeling (GO:0034367) | 2.21886825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33243382 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.15671490 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.91197510 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.73521645 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58177727 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.50738988 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39734213 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.36496206 |
| 9 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.31233372 |
| 10 | EWS_26573619_Chip-Seq_HEK293_Human | 2.27745670 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.25085035 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19315421 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15690061 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14323741 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.13712271 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.11894387 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09219441 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96110792 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.93320722 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90948657 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87313895 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.85311001 |
| 23 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.80305622 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.79137373 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.78353396 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77606951 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71283409 |
| 28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.69941925 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69357598 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.64022048 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61895520 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60165912 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.59402357 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57776335 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56991629 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56221376 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.56020985 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55473503 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55367585 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54885845 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54029990 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53912272 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.53731419 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52465181 |
| 45 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.52395117 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52365006 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52291315 |
| 48 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.51858492 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50698320 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50459877 |
| 51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48629239 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48461669 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.48015016 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46285302 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45589757 |
| 56 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.45116633 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.44485210 |
| 58 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.44098357 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43984509 |
| 60 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.43630890 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43451548 |
| 62 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.42487146 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42457571 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.42360299 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40636346 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39859650 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39859650 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39581703 |
| 69 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39343299 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38614015 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37876971 |
| 72 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.37625157 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.37557763 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37096483 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.37048346 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36371878 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35152050 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.35135160 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35113865 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34716836 |
| 81 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34262462 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33400292 |
| 83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.32668124 |
| 84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.32142481 |
| 85 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30856057 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30239771 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29844357 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29844357 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29174490 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28207813 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27407882 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26871628 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26251450 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26222100 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26149859 |
| 96 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.25729338 |
| 97 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.24440865 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.24191664 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23921283 |
| 100 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23795327 |
| 101 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23298647 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21285267 |
| 103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.20907751 |
| 104 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20479211 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20471945 |
| 106 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20151963 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18590291 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18590291 |
| 109 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18269520 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18007593 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17479166 |
| 112 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.17403664 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16968222 |
| 114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15829026 |
| 115 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15696398 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15483776 |
| 117 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15011839 |
| 118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.14782304 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14671687 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14506033 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13277026 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13269648 |
| 123 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.13254605 |
| 124 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13201218 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13201218 |
| 126 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12875538 |
| 127 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12559250 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11853497 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11803514 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11218655 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10064942 |
| 132 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09936512 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09932478 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08672248 |
| 135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08422270 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08199506 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08106368 |
| 138 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08047353 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07723852 |
| 140 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.06533135 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06475798 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06025963 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05821032 |
| 144 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05685792 |
| 145 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03875458 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03799969 |
| 147 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03507076 |
| 148 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03129914 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02827535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.51377680 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.23057986 |
| 3 | MP0003136_yellow_coat_color | 2.87495918 |
| 4 | MP0005365_abnormal_bile_salt | 2.85563780 |
| 5 | MP0004215_abnormal_myocardial_fiber | 2.79837674 |
| 6 | MP0005360_urolithiasis | 2.76331290 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.75984096 |
| 8 | MP0003195_calcinosis | 2.62572779 |
| 9 | MP0000751_myopathy | 2.52909883 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.47760808 |
| 11 | MP0004381_abnormal_hair_follicle | 2.38642174 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.25564048 |
| 13 | MP0005409_darkened_coat_color | 2.25475734 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.19664044 |
| 15 | MP0003724_increased_susceptibility_to | 2.16245600 |
| 16 | MP0005451_abnormal_body_composition | 2.16211151 |
| 17 | MP0009697_abnormal_copulation | 2.06770267 |
| 18 | MP0005171_absent_coat_pigmentation | 2.06700073 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 1.97540946 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.91723477 |
| 21 | MP0004130_abnormal_muscle_cell | 1.89586689 |
| 22 | MP0000566_synostosis | 1.87744922 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.81305172 |
| 24 | MP0001188_hyperpigmentation | 1.80940966 |
| 25 | MP0000920_abnormal_myelination | 1.79439067 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.79310981 |
| 27 | MP0003011_delayed_dark_adaptation | 1.65970340 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.62366691 |
| 29 | MP0005332_abnormal_amino_acid | 1.61068469 |
| 30 | MP0004142_abnormal_muscle_tone | 1.60545794 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.60375470 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.60326070 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.59624306 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.52004919 |
| 35 | MP0008058_abnormal_DNA_repair | 1.48488838 |
| 36 | MP0005253_abnormal_eye_physiology | 1.47461185 |
| 37 | MP0005379_endocrine/exocrine_gland_phen | 1.46769125 |
| 38 | MP0003880_abnormal_central_pattern | 1.45548989 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.44337487 |
| 40 | MP0002269_muscular_atrophy | 1.44173111 |
| 41 | MP0003690_abnormal_glial_cell | 1.40421954 |
| 42 | MP0003252_abnormal_bile_duct | 1.40334482 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.39975228 |
| 44 | MP0002102_abnormal_ear_morphology | 1.38271796 |
| 45 | MP0003718_maternal_effect | 1.36917456 |
| 46 | MP0006054_spinal_hemorrhage | 1.34116692 |
| 47 | MP0005620_abnormal_muscle_contractility | 1.33184698 |
| 48 | MP0001764_abnormal_homeostasis | 1.32440152 |
| 49 | MP0009764_decreased_sensitivity_to | 1.32325462 |
| 50 | MP0001905_abnormal_dopamine_level | 1.31474006 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.31471151 |
| 52 | MP0004742_abnormal_vestibular_system | 1.30170184 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.29490989 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.29053463 |
| 55 | MP0003941_abnormal_skin_development | 1.28301984 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.25133857 |
| 57 | MP0005369_muscle_phenotype | 1.24672836 |
| 58 | MP0008877_abnormal_DNA_methylation | 1.23847926 |
| 59 | MP0001984_abnormal_olfaction | 1.21683246 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.20205138 |
| 61 | MP0003186_abnormal_redox_activity | 1.19909289 |
| 62 | MP0004484_altered_response_of | 1.18296141 |
| 63 | MP0006082_CNS_inflammation | 1.17710240 |
| 64 | MP0003646_muscle_fatigue | 1.17097172 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.17000870 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.16711274 |
| 67 | MP0004147_increased_porphyrin_level | 1.16202280 |
| 68 | MP0002972_abnormal_cardiac_muscle | 1.15265153 |
| 69 | MP0001486_abnormal_startle_reflex | 1.14779038 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.13193897 |
| 71 | MP0000427_abnormal_hair_cycle | 1.13175441 |
| 72 | MP0005083_abnormal_biliary_tract | 1.13084366 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.12999899 |
| 74 | MP0002938_white_spotting | 1.10187929 |
| 75 | MP0004087_abnormal_muscle_fiber | 1.09965318 |
| 76 | MP0001529_abnormal_vocalization | 1.09954316 |
| 77 | MP0002009_preneoplasia | 1.09738499 |
| 78 | MP0002234_abnormal_pharynx_morphology | 1.09631960 |
| 79 | MP0005266_abnormal_metabolism | 1.09466116 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.09319710 |
| 81 | MP0000747_muscle_weakness | 1.08226226 |
| 82 | MP0002132_abnormal_respiratory_system | 1.07496483 |
| 83 | MP0002638_abnormal_pupillary_reflex | 1.07313334 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.06346460 |
| 85 | MP0000749_muscle_degeneration | 1.06051289 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.03486256 |
| 87 | MP0010386_abnormal_urinary_bladder | 1.02225111 |
| 88 | MP0005647_abnormal_sex_gland | 1.02056858 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01112565 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.99974570 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 0.99547312 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.98403886 |
| 93 | MP0002736_abnormal_nociception_after | 0.98071830 |
| 94 | MP0004085_abnormal_heartbeat | 0.97723792 |
| 95 | MP0008057_abnormal_DNA_replication | 0.97628355 |
| 96 | MP0005385_cardiovascular_system_phenoty | 0.97436099 |
| 97 | MP0001544_abnormal_cardiovascular_syste | 0.97436099 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.97229150 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.95174307 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.93908960 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.93416236 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.92929121 |
| 103 | MP0009046_muscle_twitch | 0.91487378 |
| 104 | MP0003868_abnormal_feces_composition | 0.90954969 |
| 105 | MP0000026_abnormal_inner_ear | 0.90241942 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.90201861 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.89000037 |
| 108 | MP0002272_abnormal_nervous_system | 0.88142304 |
| 109 | MP0008260_abnormal_autophagy | 0.87979383 |
| 110 | MP0005670_abnormal_white_adipose | 0.87002019 |
| 111 | MP0005187_abnormal_penis_morphology | 0.86404789 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.86217373 |
| 113 | MP0005535_abnormal_body_temperature | 0.85424113 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.83429257 |
| 115 | MP0009785_altered_susceptibility_to | 0.83217125 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.82984510 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.82969880 |
| 118 | MP0002163_abnormal_gland_morphology | 0.81864454 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.81737452 |
| 120 | MP0005423_abnormal_somatic_nervous | 0.80993364 |
| 121 | MP0000358_abnormal_cell_content/ | 0.80875945 |
| 122 | MP0008872_abnormal_physiological_respon | 0.79637833 |
| 123 | MP0000516_abnormal_urinary_system | 0.78622178 |
| 124 | MP0005367_renal/urinary_system_phenotyp | 0.78622178 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.78078533 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.76130557 |
| 127 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72905763 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.72505853 |
| 129 | MP0003787_abnormal_imprinting | 0.72293590 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.72151010 |
| 131 | MP0002971_abnormal_brown_adipose | 0.71251563 |
| 132 | MP0002160_abnormal_reproductive_system | 0.71002080 |
| 133 | MP0001963_abnormal_hearing_physiology | 0.70653160 |
| 134 | MP0002419_abnormal_innate_immunity | 0.70511507 |
| 135 | MP0001835_abnormal_antigen_presentation | 0.70291770 |
| 136 | MP0002090_abnormal_vision | 0.70276396 |
| 137 | MP0000762_abnormal_tongue_morphology | 0.69594604 |
| 138 | MP0005408_hypopigmentation | 0.68971368 |
| 139 | MP0002933_joint_inflammation | 0.67863493 |
| 140 | MP0002229_neurodegeneration | 0.67765693 |
| 141 | MP0001501_abnormal_sleep_pattern | 0.66848124 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.66428175 |
| 143 | MP0008469_abnormal_protein_level | 0.66357154 |
| 144 | MP0001661_extended_life_span | 0.65119721 |
| 145 | MP0005671_abnormal_response_to | 0.63001112 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.62110498 |
| 147 | MP0009763_increased_sensitivity_to | 0.62087530 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.61907007 |
| 149 | MP0004036_abnormal_muscle_relaxation | 0.61435777 |
| 150 | MP0005330_cardiomyopathy | 0.60895685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 4.37414425 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.24329534 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.10475450 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.03116337 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.02693079 |
| 6 | Acute encephalopathy (HP:0006846) | 3.77636098 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 3.57590064 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52717745 |
| 9 | Hepatic necrosis (HP:0002605) | 3.49517862 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.49137641 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.43900652 |
| 12 | Cerebral edema (HP:0002181) | 3.35705117 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.34256006 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.31925522 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.18824986 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.14333740 |
| 17 | Renal cortical cysts (HP:0000803) | 3.05211238 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02638305 |
| 19 | Parakeratosis (HP:0001036) | 3.01586501 |
| 20 | Pancreatic cysts (HP:0001737) | 2.93868154 |
| 21 | Increased CSF lactate (HP:0002490) | 2.93566121 |
| 22 | Methylmalonic acidemia (HP:0002912) | 2.92652536 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 2.89651629 |
| 24 | Hypothermia (HP:0002045) | 2.89349234 |
| 25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86881865 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.81566634 |
| 27 | Joint hemorrhage (HP:0005261) | 2.81201171 |
| 28 | Increased hepatocellular lipid droplets (HP:0006565) | 2.79320693 |
| 29 | Hyperalaninemia (HP:0003348) | 2.75557307 |
| 30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75557307 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 2.75557307 |
| 32 | Abnormality of the calf musculature (HP:0001430) | 2.68308010 |
| 33 | Optic disc pallor (HP:0000543) | 2.66605066 |
| 34 | Facial diplegia (HP:0001349) | 2.60604765 |
| 35 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57963355 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54035995 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 2.54035995 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.53772957 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.53086520 |
| 40 | Myoglobinuria (HP:0002913) | 2.49259916 |
| 41 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.45357482 |
| 42 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.44798404 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.42987231 |
| 44 | Glycosuria (HP:0003076) | 2.42987231 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.42444347 |
| 46 | Exercise-induced myalgia (HP:0003738) | 2.41281941 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39366224 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.39013438 |
| 49 | Rhabdomyolysis (HP:0003201) | 2.38225881 |
| 50 | Hyperlipoproteinemia (HP:0010980) | 2.37909868 |
| 51 | Lethargy (HP:0001254) | 2.37492953 |
| 52 | Lactic acidosis (HP:0003128) | 2.37021268 |
| 53 | Abnormality of renal resorption (HP:0011038) | 2.34311678 |
| 54 | Increased muscle lipid content (HP:0009058) | 2.33559515 |
| 55 | Abnormality of methionine metabolism (HP:0010901) | 2.33356988 |
| 56 | Hypophosphatemic rickets (HP:0004912) | 2.31626771 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.29911407 |
| 58 | Abnormality of secondary sexual hair (HP:0009888) | 2.28366181 |
| 59 | Abnormality of the axillary hair (HP:0100134) | 2.28366181 |
| 60 | Concave nail (HP:0001598) | 2.27499125 |
| 61 | Patchy hypopigmentation of hair (HP:0011365) | 2.27294007 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27207526 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.22367049 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21697390 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.21425844 |
| 66 | Ketosis (HP:0001946) | 2.21014512 |
| 67 | Areflexia of lower limbs (HP:0002522) | 2.20983616 |
| 68 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.20368709 |
| 69 | Absent phalangeal crease (HP:0006109) | 2.20064266 |
| 70 | Exercise intolerance (HP:0003546) | 2.19220441 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.18959167 |
| 72 | Central scotoma (HP:0000603) | 2.18112127 |
| 73 | Xanthomatosis (HP:0000991) | 2.17853145 |
| 74 | Abnormal ciliary motility (HP:0012262) | 2.17614788 |
| 75 | Hyperventilation (HP:0002883) | 2.17274702 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.14223092 |
| 77 | Nephronophthisis (HP:0000090) | 2.14010396 |
| 78 | White forelock (HP:0002211) | 2.13019531 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 2.09220791 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.09220791 |
| 81 | CNS demyelination (HP:0007305) | 2.08926803 |
| 82 | Metabolic acidosis (HP:0001942) | 2.08918536 |
| 83 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08272993 |
| 84 | Cerebral palsy (HP:0100021) | 2.08104305 |
| 85 | Abnormality of placental membranes (HP:0011409) | 2.06514431 |
| 86 | Amniotic constriction ring (HP:0009775) | 2.06514431 |
| 87 | Sudden death (HP:0001699) | 2.05055489 |
| 88 | Volvulus (HP:0002580) | 2.04819296 |
| 89 | Renal tubular dysfunction (HP:0000124) | 2.02531987 |
| 90 | Leukodystrophy (HP:0002415) | 2.02295674 |
| 91 | Abnormal finger flexion creases (HP:0006143) | 2.01358024 |
| 92 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00506013 |
| 93 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98427515 |
| 94 | Congenital primary aphakia (HP:0007707) | 1.98356591 |
| 95 | Increased serum lactate (HP:0002151) | 1.97970300 |
| 96 | Fat malabsorption (HP:0002630) | 1.97742453 |
| 97 | Palpitations (HP:0001962) | 1.97706760 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 1.97608163 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97608163 |
| 100 | Hyperglycinuria (HP:0003108) | 1.96459764 |
| 101 | Thyroid-stimulating hormone excess (HP:0002925) | 1.95964401 |
| 102 | Rimmed vacuoles (HP:0003805) | 1.95034252 |
| 103 | Hypoglycemic seizures (HP:0002173) | 1.92758194 |
| 104 | Enlarged kidneys (HP:0000105) | 1.91801119 |
| 105 | Colon cancer (HP:0003003) | 1.91226782 |
| 106 | Short tibia (HP:0005736) | 1.90339784 |
| 107 | True hermaphroditism (HP:0010459) | 1.88939552 |
| 108 | Vomiting (HP:0002013) | 1.88861745 |
| 109 | Proximal tubulopathy (HP:0000114) | 1.88075154 |
| 110 | Steatorrhea (HP:0002570) | 1.86895350 |
| 111 | Respiratory failure (HP:0002878) | 1.86576961 |
| 112 | Gait imbalance (HP:0002141) | 1.85641489 |
| 113 | Complement deficiency (HP:0004431) | 1.84212180 |
| 114 | Ketoacidosis (HP:0001993) | 1.84170989 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 1.83780874 |
| 116 | Hyperammonemia (HP:0001987) | 1.83075291 |
| 117 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82944302 |
| 118 | Fair hair (HP:0002286) | 1.82457857 |
| 119 | Symptomatic seizures (HP:0011145) | 1.81653799 |
| 120 | Abnormality of chromosome stability (HP:0003220) | 1.81540376 |
| 121 | Tubulointerstitial nephritis (HP:0001970) | 1.80379804 |
| 122 | Distal arthrogryposis (HP:0005684) | 1.80292130 |
| 123 | Abnormality of the renal medulla (HP:0100957) | 1.79456311 |
| 124 | Decreased central vision (HP:0007663) | 1.78429767 |
| 125 | Abnormality of glycolysis (HP:0004366) | 1.78047584 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.78047584 |
| 127 | Exertional dyspnea (HP:0002875) | 1.77523079 |
| 128 | Anomalous pulmonary venous return (HP:0010772) | 1.77262824 |
| 129 | Duplicated collecting system (HP:0000081) | 1.77167005 |
| 130 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.76019835 |
| 131 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.76019835 |
| 132 | Abnormality of vitamin B metabolism (HP:0004340) | 1.74196619 |
| 133 | Hyperglycinemia (HP:0002154) | 1.73608083 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 1.73607284 |
| 135 | Prolonged neonatal jaundice (HP:0006579) | 1.72960705 |
| 136 | Large for gestational age (HP:0001520) | 1.72831778 |
| 137 | Abnormality of the renal cortex (HP:0011035) | 1.72266692 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.72036875 |
| 139 | Hypoalphalipoproteinemia (HP:0003233) | 1.71924935 |
| 140 | Retinal dysplasia (HP:0007973) | 1.71485753 |
| 141 | EMG: myopathic abnormalities (HP:0003458) | 1.71109594 |
| 142 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.70976573 |
| 143 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70549545 |
| 144 | Microvesicular hepatic steatosis (HP:0001414) | 1.70348199 |
| 145 | Neck muscle weakness (HP:0000467) | 1.69905962 |
| 146 | Absent/shortened dynein arms (HP:0200106) | 1.67953177 |
| 147 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67953177 |
| 148 | Hypobetalipoproteinemia (HP:0003563) | 1.66828910 |
| 149 | Respiratory distress (HP:0002098) | 1.66814731 |
| 150 | Epidermoid cyst (HP:0200040) | 1.66608953 |
| 151 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.66262010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 6.21685532 |
| 2 | TNIK | 3.84737793 |
| 3 | STK16 | 3.24305922 |
| 4 | INSRR | 3.10132087 |
| 5 | CASK | 2.95604889 |
| 6 | FRK | 2.85237003 |
| 7 | EIF2AK3 | 2.84815458 |
| 8 | IRAK3 | 2.58610482 |
| 9 | MAP4K2 | 2.46735405 |
| 10 | BMPR1B | 2.30305096 |
| 11 | STK39 | 2.28195444 |
| 12 | TRIM28 | 2.26888086 |
| 13 | RIPK1 | 2.15463025 |
| 14 | BCKDK | 2.14740030 |
| 15 | WNK3 | 2.01504139 |
| 16 | OBSCN | 1.95243319 |
| 17 | MUSK | 1.81821563 |
| 18 | OXSR1 | 1.74286352 |
| 19 | PLK4 | 1.71045421 |
| 20 | GRK7 | 1.70669010 |
| 21 | PINK1 | 1.69775026 |
| 22 | PKN1 | 1.64518613 |
| 23 | ZAK | 1.63659573 |
| 24 | BMPR2 | 1.62444039 |
| 25 | IRAK4 | 1.58598565 |
| 26 | PBK | 1.56307272 |
| 27 | TIE1 | 1.54040641 |
| 28 | NEK2 | 1.52664674 |
| 29 | ADRBK2 | 1.50791412 |
| 30 | MAPKAPK3 | 1.50210382 |
| 31 | TXK | 1.50105060 |
| 32 | MAP3K14 | 1.49201462 |
| 33 | NUAK1 | 1.46936080 |
| 34 | MAPK15 | 1.44541303 |
| 35 | IRAK2 | 1.43966471 |
| 36 | IRAK1 | 1.43053041 |
| 37 | NEK6 | 1.40748342 |
| 38 | BLK | 1.40659665 |
| 39 | LIMK1 | 1.39442942 |
| 40 | PIK3CG | 1.38406455 |
| 41 | GRK1 | 1.36714443 |
| 42 | FLT3 | 1.35569148 |
| 43 | BUB1 | 1.33016030 |
| 44 | MAPK13 | 1.21859922 |
| 45 | MAP2K7 | 1.18802295 |
| 46 | SIK3 | 1.16269049 |
| 47 | PDK2 | 1.15925016 |
| 48 | MAPKAPK5 | 1.14978738 |
| 49 | MYLK | 1.13814296 |
| 50 | PIK3CA | 1.13646843 |
| 51 | BCR | 1.13318121 |
| 52 | TEC | 1.11675278 |
| 53 | EPHB1 | 1.09411484 |
| 54 | EIF2AK1 | 1.08965454 |
| 55 | ACVR1B | 1.08824583 |
| 56 | VRK1 | 1.08687863 |
| 57 | EIF2AK2 | 1.03956051 |
| 58 | PRKCI | 1.03613867 |
| 59 | PRPF4B | 1.01056991 |
| 60 | NLK | 0.94994538 |
| 61 | CDK19 | 0.90126073 |
| 62 | WNK4 | 0.88577695 |
| 63 | WEE1 | 0.88212758 |
| 64 | CDK3 | 0.87392210 |
| 65 | ERBB4 | 0.85614526 |
| 66 | PHKG2 | 0.85204239 |
| 67 | PHKG1 | 0.85204239 |
| 68 | MKNK2 | 0.84061473 |
| 69 | PAK3 | 0.82684199 |
| 70 | BRSK2 | 0.82383711 |
| 71 | MAP3K12 | 0.80548689 |
| 72 | EPHA4 | 0.79701177 |
| 73 | PRKCE | 0.77868831 |
| 74 | PRKCQ | 0.77463108 |
| 75 | CAMK2D | 0.77344444 |
| 76 | PLK3 | 0.76660111 |
| 77 | TRPM7 | 0.75979471 |
| 78 | IKBKE | 0.75745973 |
| 79 | CAMK2B | 0.75274412 |
| 80 | SRPK1 | 0.75095465 |
| 81 | MAP3K6 | 0.73811113 |
| 82 | MAPK12 | 0.73779715 |
| 83 | STK24 | 0.73297907 |
| 84 | CAMK2G | 0.72436264 |
| 85 | YES1 | 0.71927303 |
| 86 | DYRK2 | 0.71821278 |
| 87 | PLK2 | 0.71171995 |
| 88 | TTK | 0.70897033 |
| 89 | MAP3K4 | 0.68953993 |
| 90 | MST4 | 0.68219367 |
| 91 | TGFBR1 | 0.67009528 |
| 92 | PRKCG | 0.66190077 |
| 93 | STK3 | 0.64239963 |
| 94 | CAMK2A | 0.64006068 |
| 95 | IKBKB | 0.63236841 |
| 96 | FES | 0.61310025 |
| 97 | PRKAA2 | 0.60591754 |
| 98 | LYN | 0.59054641 |
| 99 | EPHA3 | 0.58200070 |
| 100 | AKT3 | 0.56988848 |
| 101 | AURKB | 0.56641084 |
| 102 | CLK1 | 0.56378555 |
| 103 | ADRBK1 | 0.55813938 |
| 104 | SCYL2 | 0.55410303 |
| 105 | CCNB1 | 0.54975866 |
| 106 | PRKG1 | 0.54909714 |
| 107 | RPS6KA5 | 0.53781392 |
| 108 | TSSK6 | 0.53494404 |
| 109 | PLK1 | 0.51946833 |
| 110 | ABL2 | 0.51435774 |
| 111 | CDK8 | 0.51372454 |
| 112 | KIT | 0.51074398 |
| 113 | SGK223 | 0.50351308 |
| 114 | SGK494 | 0.50351308 |
| 115 | ERBB3 | 0.49890198 |
| 116 | MAP2K6 | 0.49361957 |
| 117 | MAPK7 | 0.49231887 |
| 118 | ROCK1 | 0.49009359 |
| 119 | PRKACA | 0.48867502 |
| 120 | TESK1 | 0.48788151 |
| 121 | CSNK1G2 | 0.48617606 |
| 122 | FGFR2 | 0.46140524 |
| 123 | FER | 0.45716349 |
| 124 | FGFR1 | 0.45301905 |
| 125 | BTK | 0.45285796 |
| 126 | PRKACB | 0.44686884 |
| 127 | CSNK2A2 | 0.43783710 |
| 128 | MAP2K4 | 0.43498927 |
| 129 | NEK9 | 0.43045825 |
| 130 | DYRK1A | 0.42469267 |
| 131 | VRK2 | 0.42158677 |
| 132 | NME2 | 0.41929804 |
| 133 | TNK2 | 0.41600924 |
| 134 | MAPK4 | 0.41501806 |
| 135 | RPS6KA4 | 0.41315033 |
| 136 | STK4 | 0.41035277 |
| 137 | FGR | 0.41027852 |
| 138 | MKNK1 | 0.40935611 |
| 139 | ATM | 0.39011404 |
| 140 | PIM2 | 0.38933642 |
| 141 | TAOK3 | 0.38637233 |
| 142 | TGFBR2 | 0.37623060 |
| 143 | DAPK3 | 0.37515419 |
| 144 | CSNK1G1 | 0.37033899 |
| 145 | DYRK3 | 0.36848046 |
| 146 | CSNK1A1L | 0.36382986 |
| 147 | STK38L | 0.35518818 |
| 148 | CSNK1G3 | 0.32975329 |
| 149 | CSNK2A1 | 0.32728173 |
| 150 | ROCK2 | 0.32111018 |
| 151 | MET | 0.29446241 |
| 152 | ILK | 0.28348282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.18231335 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.95172757 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.74587115 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.60409208 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.37942654 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35485135 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34949547 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25193891 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.21189251 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.16461059 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13477008 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10014456 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.05540667 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02336752 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.00553356 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96565940 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.95452723 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93754557 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.93219872 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91793968 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83782636 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81900565 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80171672 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79398694 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77947379 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73865942 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.71902606 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71714917 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.69848872 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67557725 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65553578 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65419333 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.64938540 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63612753 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.60142114 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.57983489 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55116563 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53348567 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51876857 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50250026 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49686866 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34836613 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34106842 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33340230 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29416172 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27617033 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25687103 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25621409 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.25311456 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24646576 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24510220 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21244271 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.18430649 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15268461 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15155850 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15121395 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 1.14041216 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13776172 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13368451 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12386239 |
| 61 | Mismatch repair_Homo sapiens_hsa03430 | 1.09328088 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08259226 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07438535 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06920446 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03769928 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03505069 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02962320 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.97068994 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96871950 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92163358 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91774883 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.91409811 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91274814 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89122632 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87662220 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84839902 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83717310 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83702874 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81774045 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.77816036 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77106275 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.75349609 |
| 83 | Base excision repair_Homo sapiens_hsa03410 | 0.74948644 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71376576 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70976423 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.68580330 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67925290 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.67102578 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65705968 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65653773 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64361472 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61837541 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60743321 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.58877434 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57960413 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57395481 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57187142 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55855009 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49671093 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45985358 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45384818 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43794472 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43671039 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42048573 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.40933992 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40674637 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.39523861 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39330077 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39137981 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38232371 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37937739 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.37655365 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37340865 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36996145 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34573494 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34380899 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33209625 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33072228 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32705853 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31975382 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31568442 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28846918 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28641215 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28481023 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27295060 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26129329 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24500812 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24206118 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.23732767 |
| 130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.22622110 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.21713971 |
| 132 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.20654223 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.18219857 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18205287 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.16234448 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13527405 |
| 137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.12999389 |

